meet our

Leadership

Dr. AZA Allsop
Dr. Allsop a scientist, psychiatrist, and musician. He received his MD from Harvard Medical School, PhD in Neuroscience from MIT and was an Emerson Scholar at Berklee College of Music. He is currently the chief resident on the Clinical Neuroscience Research Unit in the Department of Psychiatry at Yale University and conducts research at the intersection of social cognition, psychedelics, music, and mindfulness. Dr. Allsop is guided by the belief that deconstructing these tools will provide a better understanding of how social groups function and offer insights into treating mental suffering and enhancing the evolution of society at large.
David Bronner
David Bronner is Cosmic Engagement Officer (CEO) of Dr. Bronner’s, the top-selling brand of natural soaps in North America and producer of a range of organic body care and food products. In addition to his support of advocacy for regenerative organic agriculture, David directs Dr. Bronner’s resources to support animal advocacy, wage equality, and drug policy reform. One of his passions is the responsible integration of cannabis and psychedelic medicine into American and global culture and he is a board member of the Multi-Disciplinary Association of Psychedelic Studies.
Julia Mirer
Dr. Julia Mirer MD is a consultant in the emerging field of psychedelic medicine, serving as a bridge between eastern and western practices, committed to merging the two in order to help create a new paradigm for integrative health and wellness. She was on the road to a career in Pediatrics, but seeing the pitfalls of the current healthcare system, decided to shift gears to explore transformative medicine where she has found her calling in advocacy and education.
Los Arias
Carlos "Los" Arias, J.D., is the Founder and CEO of Green Horizons, a large-scale cannabis business in Coachella, California. Arias is also the Principal at Psychedelics Go, a consultancy and holding company focused on the psychedelics sector. Los's mission in life is to impact the planet as an advocate for natural medicine. He is a graduate of Southwestern University School of Law in Los Angeles, and moreover has trained with multiple plant and amphibian medicine modalities in Peru, Brazil, Colombia, Ecuador, Costa Rica and Africa.
Mason Marks
Mason Marks, MD, JD is a law professor at the University of New Hampshire School of Law where he teaches Constitutional Law, Drug Policy, and Technology Law. He is Senior Fellow, Co-founder, and Lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. Mason regularly advises local, state, and federal officials on psychedelics policy and legislation.
Patrick Moher
Patrick Moher is an industrious entrepreneur working in Psychedelics and Cannabis, currently the President at Microdose Psychedelic Insights. As a passionate and unapologetic environmentalist, his relentless work ethic has directly translated to previous success in his photography career, as well as founding Ethical Image, having co-founded Alan Aldous Communications, Goodwood Accessories, UCannAcademy & and becoming a partner at ADCANN.
Satya Thallam
Satya is a policy expert and biotech executive. He has been a senior advisor in both the White House and Congress, where he led the successful effort to pass Right to Try legislation as well as promulgate the first federal legalization of cannabis via hemp regulation. He recently led the policy department at a biotech startup, leading to a multi-billion dollar IPO. He has previously been a research faculty member at George Mason University Law School. He is an advisory board member at Reason for Hope and outside advisor to Decriminalize Nature NY.
Ryan Costello
Ryan Costello is a former U.S. Congressman (PA-6) from 2015-2019 with policy expertise on technology, healthcare, energy, environment, transportation, tax, and veterans’ affairs. He served on the Committee on Energy & Commerce, which oversees a broad range of industries and policy areas, as well as the Transportation and Veterans’ Affairs committees. Currently, Ryan is a government relations executive and strategic advisor to companies, investment firms, and trade associations, who works to develop policy objectives and advocacy strategies on Capitol Hill.
Melissa Lavasani
Melissa Lavasani (she/her) is the Founder and Chief Executive Officer of Psychedelic Medicine Coalition (PMC). Prior to founding PMC, Melissa was the proposer of Washington DC’s successful 2020 ballot measure Initiative 81, the Entheogenic Plant and Fungus Policy Act. Inspired by her own experience of using plant medicines to heal her severe postpartum depression, Melissa led the Decriminalize Nature DC campaign to the largest ballot initiative victory in the history of our nation’s capital.
Daniel Carcillo
Daniel Carcillo is founder and Chief Executive Officer of Wesana Health, a biotechnology company focused on developing novel therapies for Traumatic Brain Injury related symptoms. A well-known speaker and advocate on behalf of Traumatic Brain Injury (TBI) survivors and people dealing with mental health challenges, Mr. Carcillo spent nearly a decade researching different treatment regimens and consulting experts to find effective care for his mental health conditions. In 2019, Mr. Carcillo founded Wesana, bringing together leaders in the biotech and pharmaceutical industries to move forward his vision to deliver novel pharmaceuticals that help optimize treatment outcomes for patients with mental health disorders. Prior to that, Mr. Carcillo played in the NHL for nine years and won the Stanley Cup two times.
Molly Ahearn Allen
Molly Ahearn Allen (she/her) is Chairwoman of the Board, Co-Founder, and Head of Government Affairs at Psychedelic Medicine Coalition. Molly is a Partner at American Continental Group, Inc. (ACG) where she leads the firm’s healthcare practice. Molly represents clients that cover a broad swath of the healthcare industry including hospitals, insurers, physicians, diagnostics companies, pharmacies, pharmacists, and manufacturers. In 2020, Molly was a Steering Committee Member of the Decriminalize Nature DC campaign to pass Initiative 81, the Entheogenic Plant and Fungus Policy Act.
Joe Moore
Joe Moore is Co-founder and CEO of Psychedelics Today, a platform dedicated to exploring and discussing the important academic/scientific and other research in the field of psychedelics. He began exploring psychedelics after discovering the work of transpersonal psychology founder Dr. Stanislav Grof when he was a philosophy student at Plymouth State University in 2001. Joe has been studying and practicing Grof’s Holotropic breathwork method at the Vermont-based Dreamshadow Group since 2003 and co-founded Boston Holotropic to facilitate breathwork workshops throughout New England.
Tom Zuber
Tom Zuber, Managing Partner of Zuber Lawler, is the relationship partner for many of his firm’s Fortune 500 Company clients, as well as funds, and government entities. He has represented and advised leading plant medicines companies for 15 years. He is also a founder of the magazine Psychedelia, and the psychedelics consulting company Psychedelics Now.
Robert “Roman” Haferd
Roman Haferd (he/him) is Director of Community Engagement at Psychedelic Medicine Coalition. Roman is the District of Columbia’s first Restorative Justice Coordinator at the Office of the Attorney General where he has helped build a nationally-recognized restorative justice program inside Washington DC’s Justice Department. Prior to joining the AG’s office, Roman worked as a Senior Program Associate with the Restorative Justice Project at Impact Justice, an Oakland, California-based research and innovation institute.
Daniel Conner
Daniel Conner (he/him) is Senior Vice President and Director of State and Local Affairs at the Psychedelic Medicine Coalition. Daniel has over 15 years of legislative, executive, and political experience in Washington, DC. He currently provides management and oversight for a 450+ person agency and has been a key player in DC’s involvement in C40 Cities and the Paris Agreement to combat climate change, the creation of the first Green Bank in DC, and the implementation of Clean Energy DC Omnibus Legislation.